disease 3,586 words KG: ent-dise-d0429769
Contents

ALS-FTD Spectrum

Disease Info
GRN (Progranulin)Loss-of-function mutations cause progranulin-deficient FTD (FTD-TDP type A), and some patients develop motor neuron features 10.
MAPT (Tau)Mutations in the microtubule-associated protein tau gene cause FTD-Tau, but motor neuron disease is uncommon 11.
ALSIN gene (ALS2)Juvenile-onset ALS with FTD features, caused by recessive ALSIN mutations 12.
SOD1 (Superoxide dismutase 1)First gene linked to familial ALS, but does not typically cause FTD 13.
Type A (Motor)Numerous small neurites and neuronal cytoplasmic inclusions, associated with GRN mutations and ALS
Type B (Bulbar)Moderate numbers of neuronal cytoplasmic inclusions without neurites, common in ALS-FTD with C9orf72
Type C (Cortical)Long dystrophic neurites, associated with semantic variant FTD
Type D (Hippocampal)Hippocampal neuronal inclusions, associated with VCP mutations 15
Dipeptide repeat proteinsImmunoreactive inclusions for poly-GA, poly-GR, poly-PR, and other DPRs, particularly in the frontal cortex and hippocampus 16.
Neuronal nucleolar stressThe C9orf72 repeat expansion causes nucleolar dysfunction, with TDP-43 translocating from nucleus to cytoplasm 17.
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

OMIMMeSHWikipedia

Related Hypotheses (14)

Cross-Seeding Prevention Strategy
Score: 0.69
Glycine-Rich Domain Competitive Inhibition
Score: 0.64
Cryptic Exon Silencing Restoration
Score: 0.53
Phase-Separated Organelle Targeting
Score: 0.73
Stress Granule Phase Separation Modulators
Score: 0.72
Lysosomal Enzyme Trafficking Correction
Score: 0.71
Lysosomal Calcium Channel Modulation Therapy
Score: 0.70
Axonal RNA Transport Reconstitution
Score: 0.70
Lysosomal Positioning Dynamics Modulation
Score: 0.69
Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.67
RNA Granule Nucleation Site Modulation
Score: 0.66
Serine/Arginine-Rich Protein Kinase Modulation
Score: 0.62
Lysosomal Membrane Repair Enhancement
Score: 0.54
RNA-Binding Competition Therapy for TDP-43 Cross-Seeding
Score: 0.47

Related Analyses (12)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completed
How do non-cell autonomous effects of autophagy dysfunction
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · archived

Related Experiments (30)

cGAS/STING pathway activation by TDP-43-released mtDNA
exploratory · proposed · Score: 0.95
TDP-43 mitochondrial invasion and mtDNA release in iPSC moto
exploratory · proposed · Score: 0.90
TDP-43 mutant mouse model cGAS/STING pathway analysis
validation · proposed · Score: 0.90
cGAMP biomarker analysis in ALS patient spinal cord samples
clinical · proposed · Score: 0.85
cGAMP biomarker analysis in ALS patient spinal cord samples
exploratory · proposed · Score: 0.80

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.